通过实时全球监管提交,减少手工劳动和加速患者获得新疗法. Accumulus Technologies launches a tool for real-time, global regulatory submissions, cutting manual work and speeding patient access to new therapies.

通过Accumulus Connector,药物和生物技术公司的系统与全球70多个监管机构之间实现了实时双向集成. Accumulus Technologies has launched the Accumulus Connector, enabling real-time, bidirectional integration between pharmaceutical and biotech companies’ systems and over 70 global regulatory authorities. 该平台允许单击全球监管提交和持续协作,而无需手动处理数据,减少重复并提高效率. The platform allows one-click, global regulatory submissions and continuous collaboration without manual data work, reducing duplication and improving efficiency. 它支持与当前和未来技术堆无集成,并使监管机构能够直接连接他们的系统,创建一个统一的可扩展网络. It supports seamless integration with current and future technology stacks and enables regulators to connect their systems directly, creating a unified, scalable network. 该功能可供现有Accumulus订阅者使用,旨在通过促进更透明,连接和高效的监管环境来加速患者获得治疗. The feature is available to existing Accumulus subscribers and aims to accelerate patient access to therapies by fostering a more transparent, connected, and efficient regulatory environment.